Armata Pharmaceuticals, Inc. (ARMP) Misses Q3 EPS by 60c

Armata Pharmaceuticals, Inc. (NYSE: ARMP) reported Q3 EPS of ($0.86), $0.60 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $1.2 million versus the consensus estimate of $950 thousand.

For earnings history and earnings-related data on Armata Pharmaceuticals, Inc. (ARMP) click here.

You May Also Be Interested In

• Pelagos Insurance Capital (PLGO) PT Raised to $28 at Citizens on Rising Book Value
• Oportun Financial Corp (OPRT) PT Raised to $13 at B.Riley
• Simulations Plus (SLP) Tops Q3 EPS by 7c